Abstract
The emergence of CRISPR-Cas genome editing has raised severe ethical concerns. It has been suggested that CRISPR-Cas leads to a game-changing shift in biotechnology and, in turn, in ethical perspectives on the issue. However, it is less apparent what this shift might be about and how the advent of CRISPR-Cas changes ethical debates on genome editing and moral responsibility. Against this background, this paper analyzes the advent of the CRISPR-Cas technology from a perspective of moral philosophy, focusing on the features of the technology and a particular concept of moral responsibility that is usually employed in bioethics. Individual imputability of intentional actions and their foreseeable results in case of harm is at the core of this concept. It is argued that the decisive difference of CRISPR-Cas, compared to other approaches, is its easy accessibility, efficiency and effectiveness, attracting a broad range of new user groups while on the other hand moral assessment is gaining increasing complexity. This exerts pressure on the traditional concept of individual retrospective as well as prospective moral responsibility and requires a shift in moral perspective. It is argued that this gives reason to think of moral responsibility in broader terms including more systematic accounts of forward-looking or prospective responsibility which exceed the individual level. Finally, an agenda for such an account is laid out.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Baltimore, D., Berg, P., Botchan, M., Carroll, D., Charo, R. A., Church, G., et al. (2015). Biotechnology A prudent path forward for genomic engineering and germline gene modification. Science, 348(6230), 36–38. https://doi.org/10.1126/science.aab1028.
Barrangou, R., & Doudna, J. A. (2016). Applications of CRISPR technologies in research and beyond. Nature Biotechnology, 34, 933 EP. https://doi.org/10.1038/nbt.3659.
Baumann, M. (2016). CRISPR/Cas9 genome editing—new and old ethical issues arising from a revolutionary technology. NanoEthics, 10(2), 139–159. https://doi.org/10.1007/s11569-016-0259-0.
Camporesi, S., & Cavaliere, G. (2016). Emerging ethical perspectives in the clustered regularly interspaced short palindromic repeats genome-editing debate. Personalized Medicine, 13(6), 575–586. https://doi.org/10.2217/pme-2016-0047.
Caplan, A. L., Parent, B., Shen, M., & Plunkett, C. (2015). No time to waste–the ethical challenges created by CRISPR: Crispr/cas, being an efficient, simple, and cheap technology to edit the genome of any organism, raises many ethical and regulatory issues beyond the use to manipulate human germ line cells. EMBO Reports, 16(11), 1421–1426. https://doi.org/10.15252/embr.201541337.
Carroll, D. (2017). Genome editing: Past, present, and future. The Yale Journal of Biology and Medicine, 90(4), 653–659.
Charo, R. A., & Greely, H. T. (2015). Crispr critters and CRISPR cracks. The American Journal of Bioethics: AJOB, 15(12), 11–17. https://doi.org/10.1080/15265161.2015.1104138.
Chen, K., Wang, Y., Zhang, R., Zhang, H., & Gao, C. (2019). Crispr/cas genome editing and precision plant breeding in agriculture. Annual Review of Plant Biology, 70, 667–697. https://doi.org/10.1146/annurev-arplant-050718-100049.
Cox, D. B. T., Platt, R. J., & Zhang, F. (2015). Therapeutic genome editing: Prospects and challenges. Nature Medicine, 21(2), 121–131. https://doi.org/10.1038/nm.3793.
Delfant, A. (2012). Tweaking genes in your garage: Biohacking betwenn activism and entrenpreneurship. In T. H. W. Sützl (Ed.), Activist media and biopolitics (pp. 163–178). Innsbruck s.l.: innsbruck university press.
DiCarlo, J. E., Chavez, A., Dietz, S. L., Esvelt, K. M., & Church, George M. (2015). Safeguarding CRISPR-Cas9 gene drives in yeast. Nature Biotechnology, 33(12), 1250–1255. https://doi.org/10.1038/nbt.3412.
Doudna, J. A., & Charpentier, E. (2014). Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science, 346(6213), 1258096. https://doi.org/10.1126/science.1258096.
Fritsch, J. (Ed.). (2015). Schriftenreihe zur wissenschaftsbasierten Politikberatung. Chancen und Grenzen des genome editing: The opportunities and limits of genome editing (1. Aufl.). Nationale Akademie der Wissenschaften Leopoldina, Deutsche Forschungsgemeinschaft: Halle (Saale).
Furrow, B. R. (2017). The CRISPR-Cas9 tool of gene editing: Cheaper, faster, riskier. Annals of Health Law, 26. Retrieved from https://heinonline.org/HOL/P?h=hein.journals/anohl26&i=139.
Gantz, V. M., Jasinskiene, N., Tatarenkova, O., Fazekas, A., Macias, V. M., Bier, E., et al. (2015). Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi. Proceedings of the National Academy of Sciences of the United States of America, 112(49), E6736-43. https://doi.org/10.1073/pnas.1521077112.
Gupta, R. M., & Musunuru, K. (2014). Expanding the genetic editing tool kit: Zfns, TALENs, and CRISPR-Cas9. The Journal of Clinical Investigation, 124(10), 4154–4161. https://doi.org/10.1172/JCI72992.
Hammond, A., Galizi, R., Kyrou, K., Simoni, A., Siniscalchi, C., Katsanos, D., et al. (2015). A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae. Nature biotechnology, 34, 78 EP. https://doi.org/10.1038/nbt.3439.
Heidbrink, L. (2017). Definitionen und Voraussetzungen der Verantwortung. In L. Heidbrink, C. Langbehn, & J. Loh (Eds.), Springer Reference Sozialwissenschaften Handbuch Verantwortung (pp. 3–34). Wiesbaden s.l.: Springer Fachmedien Wiesbaden.
Hsu, P. D., Lander, E. S., & Zhang, F. (2014). Development and applications of CRISPR-Cas9 for genome engineering. Cell, 157(6), 1262–1278. https://doi.org/10.1016/j.cell.2014.05.010.
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 337(6096), 816–821. https://doi.org/10.1126/science.1225829.
Jonas, H. (1985). The imperative of responsibility: In search of an ethics for the technological age (Paperback ed.). Chicago: University of Chicago Press.
Karberg, S. (2018). Spotlight 3 Gentechnologie für alle. In J. Diekämper, H. Fangerau, B. Fehse, J. Hampel, F. Hucho, K. Köchy, & M. Zenke (Eds.), Vierter Gentechnologiebericht: Bilanzierung einer Hochtechnologie (1st ed., pp. 271–276). Baden-Baden: Nomos. https://doi.org/10.5771/9783845293790-270.
Keulartz, J., & van den Belt, H. (2016). Diy-Bio-economic, epistemological and ethical implications and ambivalences. Life Sciences, Society and Policy, 12(1), 7. https://doi.org/10.1186/s40504-016-0039-1.
Kollek, R. (2013). Gentechnik. In A. Grunwald (Ed.), Handbuch Technikethik (pp. 279–287). Stuttgart: J.B. Metzler’sche.
Lanzerath, D. (2018). Ethische Kriterien und Argumente im Wandel der Zeit. In J. Diekämper, H. Fangerau, B. Fehse, J. Hampel, F. Hucho, K. Köchy, & M. Zenke (Eds.), Vierter Gentechnologiebericht: Bilanzierung einer Hochtechnologie (1st ed., pp. 103–128). Baden-Baden: Nomos. https://doi.org/10.5771/9783845293790-102.
Mahmoudian-sani, M.-R., Farnoosh, G., Mahdavinezhad, A., & Saidijam, M. (2017). CRISPR genome editing and its medical applications. Biotechnology and Biotechnological Equipment, 32(2), 286–292. https://doi.org/10.1080/13102818.2017.1406823.
Normile, D. (2018). Shock greets claim of CRISPR-edited babies. Science, 362(6418), 978–979. https://doi.org/10.1126/science.362.6418.978.
Nuffield Council on Bioethics. (2018). Genetic editing: An ethical review.
Ostheimer, J., & Vogt, M. (2008). Risikomündigkeit—Rationale Strategien im Umgang mit Komplexität. In M. Zichy & H. Grimm (Eds.), Praxis in der Ethik (pp. 185–219). Berlin, New York: Walter de Gruyter.
Rauen, V. (2017). Ethische Verantwortung. In L. Heidbrink, C. Langbehn, & J. Loh (Eds.), Springer Reference Sozialwissenschaften Handbuch Verantwortung (pp. 545–558). Wiesbaden s.l.: Springer Fachmedien Wiesbaden.
Rittel, H., & Webber, M. (1973). Dilemmas in a general theory of planning. Policy Sciences, 4, 155–169.
Roberts, N. (2000). Wicked problems and network approaches to resolution. International Public Management Review, 1(1), 1–19.
Sander, J. D., & Joung, J. K. (2014). Crispr-Cas systems for editing, regulating and targeting genomes. Nature Biotechnology, 32(4), 347–355. https://doi.org/10.1038/nbt.2842.
Seyfried, G., Pei, L., & Schmidt, M. (2014). European do-it-yourself (DIY) biology: Beyond the hope, hype and horror. BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology, 36(6), 548–551. https://doi.org/10.1002/bies.201300149.
Waag technology and society. (2018). Tegenlicht visits BioHack Academy. Retrieved from https://waag.org/en/article/tegenlicht-visits-biohack-academy.
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., et al. (2013). One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell, 153(4), 910–918. https://doi.org/10.1016/j.cell.2013.04.025.
Wilhelms, G. (2017). Systemverantwortung. In L. Heidbrink, C. Langbehn, & J. Loh (Eds.), Springer Reference Sozialwissenschaften Handbuch Verantwortung (pp. 501–524). Wiesbaden s.l.: Springer Fachmedien Wiesbaden.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Germany, part of Springer Nature
About this chapter
Cite this chapter
Haltaufderheide, J. (2020). CRISPR-Cas and the Wicked Problem of Moral Responsibility. In: Beck, B., Kühler, M. (eds) Technology, Anthropology, and Dimensions of Responsibility. Techno:Phil – Aktuelle Herausforderungen der Technikphilosophie , vol 1. J.B. Metzler, Stuttgart. https://doi.org/10.1007/978-3-476-04896-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-476-04896-7_5
Published:
Publisher Name: J.B. Metzler, Stuttgart
Print ISBN: 978-3-476-04895-0
Online ISBN: 978-3-476-04896-7
eBook Packages: J.B. Metzler Humanities (German Language)